These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12048034)

  • 1. Mechanisms of inhibition of the host interferon alpha/beta-mediated antiviral responses by viruses.
    García-Sastre A
    Microbes Infect; 2002 May; 4(6):647-55. PubMed ID: 12048034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic viruses: smart manipulators of the interferon system.
    Haller O; Weber F
    Curr Top Microbiol Immunol; 2007; 316():315-34. PubMed ID: 17969454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct cleavage, proteasomal degradation and sequestration: three mechanisms of viral subversion of type I interferon responses.
    McInerney GM; Karlsson Hedestam GB
    J Innate Immun; 2009; 1(6):599-606. PubMed ID: 20375615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The first answer to viral infections: type I interferon].
    Pichlmair A; Pollak M; Bergthaler A
    Berl Munch Tierarztl Wochenschr; 2004; 117(7-8):252-65. PubMed ID: 15298051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils.
    Stegelmeier AA; Darzianiazizi M; Hanada K; Sharif S; Wootton SK; Bridle BW; Karimi K
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interferon antiviral response: from viral invasion to evasion.
    Grandvaux N; tenOever BR; Servant MJ; Hiscott J
    Curr Opin Infect Dis; 2002 Jun; 15(3):259-67. PubMed ID: 12015460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles of Effective and Robust Innate Immune Response to Viral Infections: A Multiplex Network Analysis.
    Huang Y; Dai H; Ke R
    Front Immunol; 2019; 10():1736. PubMed ID: 31396233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interferon response to bacterial and viral infections.
    Pietras EM; Saha SK; Cheng G
    J Endotoxin Res; 2006; 12(4):246-50. PubMed ID: 16953977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Roles of Type I Interferon in Co-infections With Parasites and Viruses, Bacteria, or Other Parasites.
    Ma Y; Su XZ; Lu F
    Front Immunol; 2020; 11():1805. PubMed ID: 33193291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-stimulated genes and their antiviral effector functions.
    Schoggins JW; Rice CM
    Curr Opin Virol; 2011 Dec; 1(6):519-25. PubMed ID: 22328912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon induction by RNA viruses and antagonism by viral pathogens.
    Nan Y; Nan G; Zhang YJ
    Viruses; 2014 Dec; 6(12):4999-5027. PubMed ID: 25514371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Ecosystem of Virus-Infected Host Tissues.
    Maarouf M; Rai KR; Goraya MU; Chen JL
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral tricks to grid-lock the type I interferon system.
    Versteeg GA; García-Sastre A
    Curr Opin Microbiol; 2010 Aug; 13(4):508-16. PubMed ID: 20538505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Type 1 interferons: induction and mechanisms of antiviral action].
    Vasil'ev AN; Malinovskaia VV; Parfenov VV; Dmitrieva EV
    Antibiot Khimioter; 2009; 54(7-8):50-5. PubMed ID: 20201404
    [No Abstract]   [Full Text] [Related]  

  • 15. Putting the brakes on the anti-viral response: negative regulators of type I interferon (IFN) production.
    Richards KH; Macdonald A
    Microbes Infect; 2011 Apr; 13(4):291-302. PubMed ID: 21256242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-Cell Sensing of Viral Infection by Plasmacytoid Dendritic Cells.
    Webster B; Assil S; Dreux M
    J Virol; 2016 Nov; 90(22):10050-10053. PubMed ID: 27605675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes.
    Ng CT; Mendoza JL; Garcia KC; Oldstone MB
    Cell; 2016 Jan; 164(3):349-52. PubMed ID: 26824652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha interferon, antiviral proteins and their value in clinical medicine].
    Chieux V; Hober D; Chehadeh W; Wattré P
    Ann Biol Clin (Paris); 1999; 57(6):659-66. PubMed ID: 10572214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral strategies for evading antiviral cellular immune responses of the host.
    Iannello A; Debbeche O; Martin E; Attalah LH; Samarani S; Ahmad A
    J Leukoc Biol; 2006 Jan; 79(1):16-35. PubMed ID: 16204622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in the induction and antiviral effectors of type I interferon.
    Liu SY; Sanchez DJ; Cheng G
    Curr Opin Immunol; 2011 Feb; 23(1):57-64. PubMed ID: 21123041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.